Arachidonic acid and calcium signals in human breast tumor-derived endothelial cells: a proteomic study

References

• Carmeliet P. Angiogenesis in life, disease and medicine. Nature 2005, 438, 932–936.
   PubMed Web of Science ®Google Scholar
• Ferrara N, Kerbel RS. Angiogenesis as a therapeutic target. Nature 2005, 438, 967–974.
   PubMed Web of Science ®Google Scholar
• Griffioen AW, Molema G. Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation. Pharmacol Rev 2000, 52, 237–268.
   PubMed Web of Science ®Google Scholar
• Antoniotti S, Fiorio Pla A, Pregnolato S, Mottola A, Lovisolo D, Munaron L. Control of endothelial cell proliferation by calcium influx and arachidonic acid metabolism: a pharmacological approach. J Cell Physiol 2003, 197, 370–378.
   PubMed Web of Science ®Google Scholar
• Tamura K, Sakurai T, Kogo H. Relationship between prostaglandin E2 and vascular endothelial growth factor (VEGF) in angiogenesis in human vascular endothelial cells. Vascul Pharmacol 2006, 44, 411–416.
   PubMed Web of Science ®Google Scholar
• Calder PC. Polyunsaturated fatty acids and inflammation. Prostaglandins Leukot Essent Fatty Acids 2006, 75, 197–202.
   PubMed Web of Science ®Google Scholar
• Pidgeon GP, Lysaght J, Krishnamoorthy S, Reynolds JV, O’Byrne K, Nie D, Honn KV. Lipoxygenase metabolism: roles in tumor progression and survival. Cancer Metastasis Rev 2007, 26, 503–524.
   PubMed Web of Science ®Google Scholar
• Wang MT, Honn KV, Nie D. Cyclooxygenases, prostanoids, and tumor progression. Cancer Metastasis Rev 2007, 26, 525–534.
   PubMed Web of Science ®Google Scholar
• Fiorio Pla A, Grange C, Antoniotti S, Tomatis C, Merlino A, Bussolati B, Munaron L. Arachidonic acid-induced Ca2+ entry is involved in early steps of tumor angiogenesis. Mol Cancer Res 2008, 6, 535–545.
   PubMed Web of Science ®Google Scholar
• Munaron L. Calcium signalling and control of cell proliferation by tyrosine kinase receptors. Int J Mol Med 2002, 10, 671–676.
   PubMed Web of Science ®Google Scholar
• Shuttleworth TJ, Mignen O. Calcium entry and the control of calcium oscillations. Biochem Soc Trans 2003, 31, 916–919.
   PubMed Web of Science ®Google Scholar
• Berridge MJ, Lipp P, Bootman MD. The versatility and universality of calcium signalling. Nat Rev Mol Cell Biol 2000, 1, 11–21.
   PubMed Web of Science ®Google Scholar
• Munaron L. Intracellular calcium, endothelial cells and angiogenesis. Recent Patents Anticancer Drug Discov 2006, 1, 105–119.
   PubMed Web of Science ®Google Scholar
• Kohn EC, Liotta LA. L651582: a novel antiproliferative and antimetastasis agent. J Natl Cancer Inst 1990, 82, 54–60.
   PubMed Web of Science ®Google Scholar
• Patton AM, Kassis J, Doong H, Kohn EC. Calcium as a molecular target in angiogenesis. Curr Pharm Des 2003, 9, 543–551.
   PubMed Web of Science ®Google Scholar
• Fiorio Pla A, Munaron L. Calcium influx, arachidonic acid, and control of endothelial cell proliferation. Cell Calcium 2001, 30, 235–244.
   PubMed Web of Science ®Google Scholar
• Grange C, Bussolati B, Bruno S, Fonsato V, Sapino A, Camussi G. Isolation and characterization of human breast tumor-derived endothelial cells. Oncol Rep 2006, 15, 381–386.
   PubMed Web of Science ®Google Scholar
• Bruneel A, Labas V, Mailloux A, Sharma S, Vinh J, Vaubourdolle M, Baudin B. Proteomic study of human umbilical vein endothelial cells in culture. Proteomics 2003, 3, 714–723.
   PubMed Web of Science ®Google Scholar
• Kamino H, Hiratsuka M, Toda T, Nishigaki R, Osaki M, Ito H, Inoue T, Oshimura M. Searching for genes involved in arteriosclerosis: proteomic analysis of cultured human umbilical vein endothelial cells undergoing replicative senescence. Cell Struct Funct 2003, 28, 495–503.
   PubMed Web of Science ®Google Scholar
• Bruneel A, Labas V, Mailloux A, Sharma S, Royer N, Vinh J, Pernet P, Vaubourdolle M, Baudin B. Proteomics of human umbilical vein endothelial cells applied to etoposide-induced apoptosis. Proteomics 2005, 5, 3876–3884.
   PubMed Web of Science ®Google Scholar
• Zoeller JJ, Iozzo RV. Proteomic profiling of endorepellin angiostatic activity on human endothelial cells. Proteome Sci 2008, 6, 1–8.
   PubMed Web of Science ®Google Scholar
• Katanasaka Y, Asai T, Naitou H, Ohashi N, Oku N. Proteomic characterization of angiogenic endothelial cells stimulated with cancer cell-conditioned medium. Biol Pharm Bull 2007, 30, 2300–2307.
   PubMed Web of Science ®Google Scholar
• Cai H, Gehrig P, Scott TM, Zimmermann R, Schlapbach R, Zisch AH. MnSOD marks cord blood late outgrowth endothelial cells and accompanies robust resistance to oxidative stress. Biochem Biophys Res Commun 2006, 350, 364–369.
   PubMed Web of Science ®Google Scholar
• Keezer SM, Ivie SE, Krutzsch HC, Tandle A, Libutti SK, Roberts DD. Angiogenesis inhibitors target the endothelial cell cytoskeleton through altered regulation of heat shock protein 27 and cofilin. Cancer Res 2003, 63, 6405–6412.
   PubMed Web of Science ®Google Scholar
• Franzén B, Duvefelt K, Jonsson C, Engelhardt B, Ottervald J, Wickman M, Yang Y, Schuppe-Koistinen I. Gene and protein expression profiling of human cerebral endothelial cells activated with tumor necrosis factor-alpha. Brain Res Mol Brain Res 2003, 115, 130–146.
   PubMedGoogle Scholar
• Bohman S, Matsumoto T, Suh K, Dimberg A, Jakobsson L, Yuspa S, Claesson-Welsh L. Proteomic analysis of vascular endothelial growth factor-induced endothelial cell differentiation reveals a role for chloride intracellular channel 4 (CLIC4) in tubular morphogenesis. J Biol Chem 2005, 280, 42397–42404.
   PubMed Web of Science ®Google Scholar
• Haqqani AS, Kelly J, Baumann E, Haseloff RF, Blasig IE, Stanimirovic DB. Protein markers of ischemic insult in brain endothelial cells identified using 2D gel electrophoresis and ICAT-based quantitative proteomics. J Proteome Res 2007, 6, 226–239.
   PubMed Web of Science ®Google Scholar
• Lu L, Yang PY, Rui YCh, Kang H, Zhang J, Zhang JP, Feng WH. Comparative proteome analysis of rat brain and coronary microvascular endothelial cells. Physiol Res 2007, 56, 159–168.
   PubMed Web of Science ®Google Scholar
• Zamora DO, Riviere M, Choi D, Pan Y, Planck SR, Rosenbaum JT, David LL, Smith JR. Proteomic profiling of human retinal and choroidal endothelial cells reveals molecular heterogeneity related to tissue of origin. Mol Vis 2007, 13, 2058–2065.
   PubMed Web of Science ®Google Scholar
• Park HJ, Kim BG, Lee SJ, Heo SH, Kim JY, Kwon TH, Lee EB, Ryoo HM, Cho JY. Proteomic profiling of endothelial cells in human lung cancer. J Proteome Res 2008, 7, 1138–1150.
   PubMed Web of Science ®Google Scholar
• Hewitson JP, Harcus YM, Curwen RS, Dowle AA, Atmadja AK, Ashton PD, Wilson A, Maizels RM. The secretome of the filarial parasite, Brugia malayi: proteomic profile of adult excretory-secretory products. Mol Biochem Parasitol 2008, 160, 8–21.
   PubMed Web of Science ®Google Scholar
• Cassimeris L. The oncoprotein 18/stathmin family of microtubule destabilizers. Curr Opin Cell Biol 2002, 14, 18–24.
   PubMed Web of Science ®Google Scholar
• Mistry SJ, Atweh GF. Role of stathmin in the regulation of the mitotic spindle: potential applications in cancer therapy. Mt Sinai J Med 2002, 69, 299–304.
   PubMed Web of Science ®Google Scholar
• Campostrini N, Marimpietri D, Totolo A, Mancone C, Fimia GM, Ponzoni M, Righetti PG. Proteomic analysis of anti-angiogenic effects by a combined treatment with vinblastine and rapamycin in an endothelial cell line. Proteomics 2006, 6, 4420–4431.
   PubMed Web of Science ®Google Scholar
• Miyashita H, Kanemura M, Yamazaki T, Abe M, Sato Y. Vascular endothelial zinc finger 1 is involved in the regulation of angiogenesis: possible contribution of stathmin/OP18 as a downstream target gene. Arterioscler Thromb Vasc Biol 2004, 24, 878–884.
   PubMed Web of Science ®Google Scholar
• Mistry SJ, Bank A, Atweh GF. Synergistic antiangiogenic effects of stathmin inhibition and taxol exposure. Mol Cancer Res 2007, 5, 773–782.
   PubMed Web of Science ®Google Scholar
• Melander Gradin H, Marklund U, Larsson N, Chatila TA, Gullberg M. Regulation of microtubule dynamics by Ca2+/ calmodulin-dependent kinase IV/Gr-dependent phosphorylation of oncoprotein 18. Mol Cell Biol 1997, 17, 3459–3467.
   PubMed Web of Science ®Google Scholar
• Boissan M, Wendum D, Arnaud-Dabernat S, Munier A, Debray M, Lascu I, Daniel JY, Lacombe ML. Increased lung metastasis in transgenic NM23-Null/SV40 mice with hepatocellular carcinoma. J Natl Cancer Inst 2005, 97, 836–845.
   PubMedGoogle Scholar
• Palmieri D, Horak CE, Lee JH, Halverson DO, Steeg PS. Translational approaches using metastasis suppressor genes. J Bioenerg Biomembr 2006, 38, 151–156.
   PubMed Web of Science ®Google Scholar
• Horak CE, Mendoza A, Vega-Valle E, Albaugh M, Graff-Cherry C, McDermott WG, Hua E, Merino MJ, Steinberg SM, Khanna C, Steeg PS. Nm23-H1 suppresses tumor cell motility by down-regulating the lysophosphatidic acid receptor EDG2. Cancer Res 2007, 67, 7238–7246.
   PubMed Web of Science ®Google Scholar
• Ushio-Fukai M, Nakamura Y. Reactive oxygen species and angiogenesis: NADPH oxidase as target for cancer therapy. Cancer Lett 2008, 266, 37–52.
   PubMed Web of Science ®Google Scholar
• Marikovsky M, Nevo N, Vadai E, Harris-Cerruti C. Cu/Zn superoxide dismutase plays a role in angiogenesis. Int J Cancer 2002, 97, 34–41.
   PubMed Web of Science ®Google Scholar
• Juarez JC, Betancourt O Jr, Pirie-Shepherd SR, Guan X, Price ML, Shaw DE, Mazar AP, Doñate F. Copper binding by tetrathiomolybdate attenuates angiogenesis and tumor cell proliferation through the inhibition of superoxide dismutase 1. Clin Cancer Res 2006, 12, 4974–4982.
   PubMed Web of Science ®Google Scholar
• Juarez JC, Manuia M, Burnett ME, Betancourt O, Boivin B, Shaw DE, Tonks NK, Mazar AP, Doñate F. Superoxide dismutase 1 (SOD1) is essential for H2O2-mediated oxidation and inactivation of phosphatases in growth factor signaling. Proc Natl Acad Sci USA 2008, 105, 7147–7152.
   PubMed Web of Science ®Google Scholar
• Lounsbury KM, Hu Q, Ziegelstein RC. Calcium signaling and oxidant stress in the vasculature. Free Radic Biol Med 2000, 28, 1362–1369.
   PubMed Web of Science ®Google Scholar
• Maines MD. New insights into biliverdin reductase functions: linking heme metabolism to cell signaling. Physiology (Bethesda) 2005, 20, 382–389.
   PubMed Web of Science ®Google Scholar
• Baravano DE, Rao M, Ferris CD, Snyder SH. Biliverdin reductase: a major physiologic cytoprotectant. Proc Natl Acad Sci USA 2002, 99, 16093–16098.
   PubMed Web of Science ®Google Scholar
• Lerner-Marmarosh N, Shen J, Torno MD, Kravets A, Hu Z, Maines MD. Human biliverdin reductase: a member of the insulin receptor substrate family with serine/threonine/tyrosine kinase activity. Proc Natl Acad Sci USA 2005, 102, 7109–7114.
   PubMed Web of Science ®Google Scholar
• Lerner-Marmarosh N, Miralem T, Gibbs PE, Maines MD. Human biliverdin reductase is an ERK activator; hBVR is an ERK nuclear transporter and is required for MAPK signaling. Proc Natl Acad Sci USA 2008, 105, 6870–6875.
   PubMed Web of Science ®Google Scholar
• Gebauer F, Hentze MW. Molecular mechanisms of translational control. Nat Rev Mol Cell Biol 2004, 5, 827–835.
   PubMed Web of Science ®Google Scholar
• Rajasekhar VK, Holland EC. Postgenomic global analysis of translational control induced by oncogenic signaling. Oncogene 2004, 23, 3248–3264.
   PubMed Web of Science ®Google Scholar
• Ahlemann M, Zeidler R, Lang S, Mack B, Münz M, Gires O. Carcinoma-associated eIF3i overexpression facilitates mTOR-dependent growth transformation. Mol Carcinog 2006, 45, 957–967.
   PubMed Web of Science ®Google Scholar
• Bell AW, Ward MA, Blackstock WP, Freeman HN, Choudhary JS, Lewis AP, Chotai D, Fazel A, Gushue JN, Paiement J, Palcy S, Chevet E, Lafrenière-Roula M, Solari R, Thomas DY, Rowley A, Bergeron JJ. Proteomics characterization of abundant Golgi membrane proteins. J Biol Chem 2001, 276, 5152–5165.
   PubMed Web of Science ®Google Scholar
• Nakashima-Kamimura N, Asoh S, Ishibashi Y, Mukai Y, Shidara Y, Oda H, Munakata K, Goto Y, Ohta S. MIDAS/GPP34, a nuclear gene product, regulates total mitochondrial mass in response to mitochondrial dysfunction. J Cell Sci 2005, 118, 5357–5367.
   PubMed Web of Science ®Google Scholar